These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1932621

  • 1. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems.
    Beuth J, Ko HL, Gabius HJ, Pulverer G.
    In Vivo; 1991; 5(1):29-32. PubMed ID: 1932621
    [Abstract] [Full Text] [Related]

  • 2. Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
    Braun JM, Ko HL, Schierholz JM, Beuth J.
    Anticancer Res; 2002; 22(6C):4187-90. PubMed ID: 12553054
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of immune responses to neem leaf extract (Azadirachta indica) correlates with antineoplastic activity in BALB/c-mice.
    Beuth J, Schneider H, Ko HL.
    In Vivo; 2006; 20(2):247-51. PubMed ID: 16634526
    [Abstract] [Full Text] [Related]

  • 4. Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.
    Schaffrath B, Mengs U, Schwarz T, Hilgers RD, Beuth J, Möckel B, Lentzen H, Gerstmayer B.
    Anticancer Res; 2001; 21(6A):3981-7. PubMed ID: 11911280
    [Abstract] [Full Text] [Related]

  • 5. Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract.
    Beuth J, Stoffel B, Ko HL, Jeljaszewicz J, Pulverer G.
    Arzneimittelforschung; 1995 Nov; 45(11):1240-2. PubMed ID: 8929248
    [Abstract] [Full Text] [Related]

  • 6. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.
    Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G.
    In Vivo; 1994 Nov; 8(6):989-92. PubMed ID: 7772751
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunomodulating efficacy of combined administration of galactoside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice.
    Stoffel B, Krämer K, Mayer H, Beuth J.
    Anticancer Res; 1997 Nov; 17(3C):1893-6. PubMed ID: 9216641
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The immunomodulatory beta-galactoside-specific lectin from mistletoe: partial sequence analysis, cell and tissue binding, and impact on intracellular biosignalling of monocytic leukemia cells.
    Gabius HJ, Walzel H, Joshi SS, Kruip J, Kojima S, Gerke V, Kratzin H, Gabius S.
    Anticancer Res; 1992 Nov; 12(3):669-75. PubMed ID: 1622124
    [Abstract] [Full Text] [Related]

  • 15. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.
    Heiny BM, Beuth J.
    Anticancer Res; 1994 Nov; 14(3B):1339-42. PubMed ID: 8067703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.